13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-36

Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance

Hugo Ector, Tony Reybrouck*°, Hein Heidbüchel, Marc Gewillig*, Frans Van de Werf.
Departments of Cardiology, *Pediatric Cardiology and °Cardiovascular Rehabilitation, University Hospital Gasthuisberg, Leuven, Belgium

Although the neurally mediated syncopal syndromes are the most frequent causes of fainting episodes in humans, our understanding of the pathophysiology and appropriate management of these conditions has been slow to progress1,2. In the assessment of syncope, the head-up tilt table test, is the appropriate diagnostic tool3. A wide variety of medical treatments have been proposed: disopyramide, beta-blocking agents, fludrocortisone, theophylline, clonidine, ephedrine, etilephrine, salt and fluid supplements, serotonin reuptake inhibitors, sleeping in a head-up bed, cardiac pacing4-8. However, this multitude of strategies reflects the unpredictable and unsatisfactory therapeutic results. In patients undergoing repeated tilt table tests, we have experienced a prompt improvement in tilt tolerance. We hypothesized, that the repeated and prolonged exposure of the cardiovascular system to gravitational stress, might have a therapeutic effect in patients with orthostatic intolerance. We have initiated a rehabilitation program of systematic tilt training in a group of patients with recurrent syncope and orthostatic intolerance.

 

backward

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.